Recombinant Helicobacter pylori Triosephosphate isomerase (tpiA)

Shipped with Ice Packs
In Stock

Description

Functional Role in Metabolism

HpTIM is essential for glycolysis and gluconeogenesis, enabling H. pylori to thrive in the gastric mucosa. Key functional insights:

  • Kinetic Parameters:

    • KmK_m (G3P): 3.46±0.23mM3.46 \pm 0.23 \, \text{mM}

    • kcatk_{\text{cat}}: 8.8×104min18.8 \times 10^4 \, \text{min}^{-1}

  • Side Reaction: Generates methylglyoxal, a cytotoxic compound linked to host tissue damage .

Recombinant Expression and Purification

HpTIM has been successfully expressed in Escherichia coli:

  • Cloning: The tpiA gene was inserted into expression vectors (e.g., pET3aHisTEVP) and transformed into E. coli BL21(DE3) .

  • Purification: Affinity chromatography (e.g., Ni Sepharose) yields >95% pure protein, validated by SDS-PAGE .

  • Tag Removal: A TEV protease-cleavable His-tag facilitates native-like protein recovery .

Implications for Pathogenicity and Drug Development

While not directly a virulence factor, HpTIM’s essential role makes it a potential therapeutic target:

  • Gene Conservation: tpiA shows minimal sequence variation across H. pylori strains, despite high genomic recombination rates .

  • Inhibitor Potential: Structural homology with human TIM complicates drug design, but differences in loop dynamics or surface residues could be exploited .

Research Gaps and Future Directions

  • In Vivo Studies: Impact of HpTIM inhibition on H. pylori colonization remains unexplored.

  • Allosteric Regulation: Potential redox-sensitive modifications or interactions with other H. pylori proteins (e.g., HP1021-regulated genes ) warrant investigation.

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will try to accommodate.
Lead Time
Delivery times vary based on purchasing method and location. Contact your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipping, please contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tpiA; HPSH_00995; Triosephosphate isomerase; TIM; TPI; EC 5.3.1.1; Triose-phosphate isomerase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-234
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Helicobacter pylori (strain Shi470)
Target Names
tpiA
Target Protein Sequence
MTKIAMANFK SAMPIFKSHA YLEELEKTLK PQHFDRVFVF PDFLGLLPNS FLHFTLGAQN AYPKDCGAFT GEITSQHLEE LKINTLLIGH SERRLLLKES PSFLKEKFDF FKSKNFKIVY CIGEELTTRE KGFKAVKEFL NEQLENIDLN YPNLVVAYEP IWAIGTKKSA SLEDIYLTHG FLKQILNQKT PLLYGGSVNA QNAKEILGID SVDGLLIGSA SLELENFKTI ISFL
Uniprot No.

Target Background

Function
Involved in gluconeogenesis. Catalyzes the stereospecific conversion of dihydroxyacetone phosphate (DHAP) to D-glyceraldehyde-3-phosphate (G3P).
Database Links
Protein Families
Triosephosphate isomerase family
Subcellular Location
Cytoplasm.

Q&A

What is Helicobacter pylori Triosephosphate isomerase (tpiA) and what is its metabolic significance?

Helicobacter pylori Triosephosphate isomerase (encoded by the tpiA gene) is a critical enzyme in the glycolytic pathway that catalyzes the reversible interconversion between dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde-3-phosphate (GAP) in the glycolysis-gluconeogenesis metabolic pathway . This isomerization step is essential for H. pylori's energy production, as it allows the bacterium to efficiently process glucose through glycolysis. The enzyme ensures that both three-carbon products from the aldolase reaction can proceed through the energy-yielding steps of glycolysis, effectively maximizing ATP yield from glucose metabolism.

H. pylori depends heavily on this enzyme due to its limited metabolic flexibility compared to many other bacteria. Given its essential role in bacterial metabolism and the structural differences between bacterial and human homologs, tpiA represents a potential antimicrobial target for treating H. pylori infections, which are recognized as one of the prevalent causes of human gastric infection .

How is recombinant H. pylori Triosephosphate isomerase expressed and purified?

The production of recombinant H. pylori Triosephosphate isomerase typically follows established molecular biology protocols:

Expression system:

  • The H. pylori tpiA gene is cloned into an appropriate expression vector

  • Transformation into an E. coli expression host (commonly BL21(DE3) strain)

  • Protein expression is induced under optimized conditions

Purification methodology:

  • Cell lysis using mechanical or chemical methods

  • Initial capture using affinity chromatography (if the construct includes a tag)

  • Further purification via ion exchange and/or size exclusion chromatography

  • Quality assessment through SDS-PAGE and activity assays

According to published research, the H. pylori TIM gene has been successfully cloned, and the protein expressed and purified for structural and functional characterization . The purified enzyme should be assessed for homogeneity and catalytic activity before proceeding with experimental applications.

What are the structural characteristics of H. pylori Triosephosphate isomerase?

Crystallographic analysis has revealed several distinctive structural features of H. pylori Triosephosphate isomerase:

These structural characteristics provide insights into the enzyme's catalytic mechanism and may contribute to its adaptation to the acidic environment of the human stomach where H. pylori resides.

How does H. pylori Triosephosphate isomerase compare to TIM from other organisms?

H. pylori Triosephosphate isomerase shares fundamental catalytic mechanisms with TIMs from other species while exhibiting several distinguishing features:

Table 1: Comparative Analysis of TIM Properties Across Species

PropertyH. pylori TIME. coli TIMHuman TIMYeast TIM
Barrel Structure(β/α)β(β/α)6(β/α)8(β/α)8(β/α)8
Km for GAP (mM)3.46 ± 0.23~0.5~0.3~0.4
kcat (min-1)8.8 × 104~4 × 105~5 × 105~4 × 105
Catalytic Efficiency (kcat/Km)2.5 × 104~8 × 105~1.7 × 106~1 × 106
Key Structural FeatureMissing helix after β2Complete barrelComplete barrelComplete barrel

The higher Km value (3.46 mM) for H. pylori TIM indicates lower substrate affinity compared to TIMs from other organisms . Despite this, the enzyme maintains sufficient catalytic efficiency to support H. pylori metabolism. The unique structural features may reflect adaptations to the specialized niche of H. pylori in the human gastric environment, where it must function under acidic conditions not encountered by many other organisms.

What are the kinetic parameters of recombinant H. pylori Triosephosphate isomerase?

The kinetic behavior of recombinant H. pylori Triosephosphate isomerase has been characterized through steady-state enzyme kinetics, revealing important information about its catalytic properties:

For the substrate glyceraldehyde-3-phosphate (GAP):

  • Km = 3.46 ± 0.23 mM

  • kcat = 8.8 × 104 min-1

  • kcat/Km = 2.5 × 104 min-1 mM-1

These parameters provide several insights into the enzyme's function:

  • The relatively high Km value indicates lower substrate affinity compared to TIMs from other organisms

  • The substantial turnover number (kcat) demonstrates that each enzyme molecule can process many substrate molecules per minute

  • The catalytic efficiency (kcat/Km ratio) reflects how effectively the enzyme performs at subsaturating substrate concentrations

These kinetic parameters are typically determined using continuous spectrophotometric assays that couple the TIM reaction to other enzymatic reactions, allowing convenient monitoring of reaction progress through changes in absorbance at specific wavelengths.

What methods are utilized to assess the enzymatic activity of recombinant H. pylori Triosephosphate isomerase?

Several complementary methodological approaches are employed to characterize the enzymatic activity of recombinant H. pylori Triosephosphate isomerase:

Coupled enzyme assays:

  • Forward direction (GAP → DHAP): TIM activity coupled to α-glycerophosphate dehydrogenase, monitoring NADH oxidation at 340 nm

  • Reverse direction (DHAP → GAP): TIM activity coupled to glyceraldehyde-3-phosphate dehydrogenase, tracking NADH formation at 340 nm

Direct measurement methods:

  • NMR spectroscopy: Permits direct observation of substrate-product interconversion

  • Mass spectrometry: Enables quantitative analysis of reaction components over time

  • HPLC analysis: Allows separation and quantification of substrate and product

Advanced kinetic techniques:

  • Stopped-flow spectroscopy: Provides insights into pre-steady-state kinetics

  • Isothermal titration calorimetry: Measures thermodynamic parameters of binding and catalysis

The selection of appropriate methods depends on the specific research question, available instrumentation, and desired precision. Often, researchers employ multiple complementary techniques to build a comprehensive understanding of enzymatic behavior under various conditions.

How stable is recombinant H. pylori Triosephosphate isomerase under different experimental conditions?

Understanding the stability profile of recombinant H. pylori Triosephosphate isomerase is crucial for experimental design and implementation:

pH stability:

  • Optimal activity typically observed in the pH range of 6.5-8.0

  • Likely exhibits enhanced acid stability given H. pylori's adaptation to the acidic gastric environment

  • The enzyme may retain structural integrity at lower pH even when catalytic efficiency is reduced

Temperature dependence:

  • Maximum activity around 37°C (human body temperature)

  • Thermal denaturation generally begins at temperatures above 50-55°C

  • Low-temperature storage (4°C) suitable for short-term preservation; freezing (-20°C or -80°C) required for long-term storage

Chemical stability considerations:

  • Sensitivity to oxidizing agents that can modify catalytic residues

  • Addition of reducing agents (1-5 mM DTT or β-mercaptoethanol) helps maintain activity

  • Potential inhibition by specific anions or metal ions that may interfere with substrate binding

Storage recommendations:

  • Addition of 10-20% glycerol as a cryoprotectant prevents freeze-thaw damage

  • Minimizing freeze-thaw cycles extends enzyme shelf-life

  • Regular activity testing recommended after prolonged storage

Researchers should empirically determine the specific stability profile for their recombinant H. pylori TIM preparation, as expression systems, purification protocols, and storage conditions can all influence enzyme stability characteristics.

What structural elements are critical for H. pylori Triosephosphate isomerase function?

Several key structural elements work in concert to enable the catalytic function of H. pylori Triosephosphate isomerase:

Catalytic residues:

  • Four critical amino acids form the active site: Asn11, Lys13, His95, and Glu167

  • Glu167 functions as the catalytic base essential for proton transfer during catalysis

  • Asn11 and His95 contribute to substrate positioning within the active site

  • Lys13 stabilizes developing negative charge on reaction intermediates

Dynamic loop elements:

  • Loop-6 (containing Glu167) undergoes significant conformational change upon substrate binding

  • The closed conformation shields the active site from bulk solvent, creating an environment that stabilizes the high-energy enediolate intermediate

  • The Glu167 side chain moves approximately 2 Å toward the substrate when loop-6 closes

  • Loop-7 also participates in establishing the catalytically competent active site architecture

Quaternary structure:

  • Dimerization is essential for full catalytic activity

  • Although catalytic residues come from a single subunit, the dimer interface influences active site geometry

  • Specific interface interactions maintain the quaternary structure needed for optimal function

Conserved structural motifs:

  • Despite the modified barrel fold, key structural elements maintain the spatial relationships necessary for catalysis

  • The C-terminal ends of β-strands form the substrate-binding pocket

  • The missing helix after the second β-strand represents a unique structural feature that distinguishes H. pylori TIM

Understanding these structural elements provides fundamental insights into the enzyme's catalytic mechanism and offers potential targets for structure-based enzyme engineering or inhibitor design approaches.

How can site-directed mutagenesis be used to study the catalytic mechanism of H. pylori Triosephosphate isomerase?

Site-directed mutagenesis represents a powerful approach for dissecting the catalytic mechanism of H. pylori Triosephosphate isomerase through strategic amino acid substitutions:

Table 2: Strategic Mutagenesis Targets and Expected Outcomes

Target ResidueMutation TypePredicted EffectMethodological Analysis
Glu167E167D (conservative)Altered proton transfer capacitypH-rate profiles, pre-steady state kinetics
Glu167E167Q (non-conservative)Severely reduced activityQuantification of residual activity
His95H95N/H95QModified substrate positioningBinding affinity determination, structural analysis
Asn11N11ADisrupted hydrogen bonding networkSubstrate specificity analysis
Lys13K13R/K13MAltered electrostatic environmentKinetic analysis with charged/neutral substrates
Loop-6 residuesGlycine insertionsModified loop flexibilityLoop dynamics analysis via HDX-MS or NMR
Dimer interfaceHydrophobic→PolarQuaternary structure disruptionSize-exclusion chromatography, activity correlation

Experimental design considerations:

  • Create mutation libraries targeting specific functional regions

  • Express and purify mutant proteins using identical protocols to wild-type

  • Conduct parallel characterization to enable direct comparisons

  • Combine kinetic, thermodynamic, and structural analyses for comprehensive assessment

Advanced analytical approaches:

  • Hydrogen-deuterium exchange mass spectrometry to map conformational changes

  • Pre-steady-state kinetics to identify rate-limiting steps affected by mutations

  • X-ray crystallography of mutant enzymes to visualize structural perturbations

  • Molecular dynamics simulations to predict and interpret mutation effects

This systematic mutagenesis strategy can reveal the precise contributions of individual residues to catalysis, substrate binding, and conformational dynamics, ultimately providing a detailed mechanistic understanding of H. pylori TIM function.

What are the challenges in crystallizing recombinant H. pylori Triosephosphate isomerase?

Obtaining high-quality crystals of recombinant H. pylori Triosephosphate isomerase presents several specific challenges that researchers must address:

Sample preparation hurdles:

  • Achieving extreme protein purity (>98%) typically requires multiple chromatography steps

  • Ensuring conformational homogeneity, particularly challenging due to mobile catalytic loops

  • Determining optimal protein concentration (typically 5-20 mg/mL for TIMs)

  • Maintaining protein stability during concentration processes

Crystallization challenges:

  • Managing the conformational flexibility of loop-6 and loop-7, which can introduce heterogeneity

  • Controlling oligomerization state to ensure consistent dimerization

  • Identifying appropriate crystallization conditions from thousands of possible combinations

  • Obtaining crystals that diffract to high resolution (beyond 2.0 Å) for detailed structural analysis

Strategic approaches:

  • Co-crystallization with substrate analogs or inhibitors to stabilize specific conformational states

  • Surface entropy reduction through mutation of high-entropy surface residues

  • Implementation of microseeding techniques to control nucleation and crystal growth

  • Screening diverse crystallization conditions using automated high-throughput methods

Post-crystallization considerations:

  • Optimizing cryoprotection protocols to prevent ice formation during flash-cooling

  • Managing radiation damage during X-ray data collection

  • Phase determination, which may require heavy atom derivatives or molecular replacement

The successful crystallization of H. pylori TIM at 2.3 Å resolution demonstrates that these challenges can be overcome through systematic optimization . Researchers should consider employing an iterative approach, using initial crystallization hits to guide further refinement.

How does the conformational dynamics of H. pylori Triosephosphate isomerase contribute to its catalytic efficiency?

The conformational dynamics of H. pylori Triosephosphate isomerase plays a crucial role in its catalytic mechanism and efficiency:

Loop dynamics and the catalytic cycle:

  • Loop-6 undergoes significant conformational changes, transitioning between "open" and "closed" states

  • Upon substrate binding, loop-6 closure positions Glu167 approximately 2 Å closer to the substrate

  • The closed conformation creates a protected active site environment that:

    • Shields the high-energy enediolate intermediate from bulk solvent

    • Prevents side reactions that would reduce catalytic efficiency

    • Positions catalytic residues optimally for proton transfer

Temporal aspects of dynamics:

  • Loop motions occur on the microsecond to millisecond timescale

  • The synchronization between chemical steps and conformational changes affects turnover rate

  • The dynamic properties may be influenced by H. pylori's modified TIM barrel fold

Methodological approaches to study dynamics:

  • NMR relaxation experiments to characterize motions at various timescales

  • Hydrogen-deuterium exchange mass spectrometry to identify regions with dynamic solvent accessibility

  • Molecular dynamics simulations to provide atomic-level insights into conformational transitions

  • Single-molecule FRET to directly observe opening and closing events

The unique structural features of H. pylori TIM, particularly its modified barrel fold with a missing helix after the second β-strand, may influence the enzyme's dynamics in ways that distinguish it from canonical TIMs . Understanding these dynamics can provide insights into how the enzyme has evolved to function in the specialized environment of H. pylori and may guide efforts to develop selective inhibitors.

What potential exists for targeting H. pylori Triosephosphate isomerase for antimicrobial drug development?

H. pylori Triosephosphate isomerase represents a promising target for antimicrobial development based on several key considerations:

Biological rationale:

  • Essential role in glycolytic energy production in H. pylori, which has limited metabolic flexibility

  • High conservation across H. pylori strains, potentially reducing the rate of resistance development

  • Structural differences from the human homolog that could enable selective targeting

Table 3: Potential Targeting Strategies for H. pylori TIM Inhibition

Target SiteInhibition StrategyAdvantagesChallenges
Active siteCompetitive inhibitorsDirect interference with catalysisAchieving selectivity over human TIM
Catalytic loopsConformational stabilizersPrevention of essential dynamicsTargeting protein motion effectively
Dimer interfaceQuaternary structure disruptorsUnique interface compositionComplex binding site architecture
Allosteric sitesConformational modulatorsPotential for high selectivityIdentifying effective binding pockets
Strain-specific regionsSelective targetingReduced off-target effectsMay limit spectrum of activity

Drug development approaches:

  • Structure-based design of transition state analogs with specificity for bacterial TIM

  • Fragment-based screening to identify novel chemical scaffolds with activity against H. pylori TIM

  • Computational strategies to identify compounds that selectively stabilize inactive conformations

  • Peptide-based inhibitors that disrupt essential protein-protein interactions

Translational considerations:

  • Developing compounds with appropriate pharmacokinetic properties for gastric delivery

  • Ensuring stability in the acidic environment where H. pylori resides

  • Combining TIM inhibitors with existing anti-H. pylori therapies for synergistic effects

Given the growing concern of antibiotic resistance in H. pylori and the limitations of current treatment regimens , novel targets such as TIM could provide valuable additions to the therapeutic arsenal. The development of selective TIM inhibitors would represent a mechanism-based approach to H. pylori eradication, potentially offering advantages over broader-spectrum antibiotics.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.